Mechanisms of disease: proatherogenic HDL--an evolving field. - Wikidata - awgldk - TriplyDB

Mechanisms of disease: proatherogenic HDL--an evolving field.

Mechanisms of disease: proatherogenic HDL--an evolving field.

http://www.wikidata.org/entity/Q36587579

about

Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis Haptoglobin genotype and its role in determining heme-iron mediated vascular disease The therapeutic role of niacin in dyslipidemia management Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL HDL in humans with cardiovascular disease exhibits a proteomic signature.High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.Interaction of HDL cholesterol concentrations on the relationship between physical function and inflammation in community-dwelling older persons.Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.Atherothrombosis in South asians: implications of atherosclerotic and inflammatory markers.Lipid packing determines protein-membrane interactions: challenges for apolipoprotein A-I and high density lipoproteins.Genetic causes of high and low serum HDL-cholesterol.The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.Association of serum uric acid and coronary artery disease in premenopausal women.Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry Markers of Systemic Inflammation and Apo-AI Containing HDL Subpopulations in Women with and without Diabetes High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.Carotid intima media thickness and low high-density lipoprotein (HDL) in South Asian immigrants: could dysfunctional HDL be the missing link?Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women.Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions.C-reactive protein and lipid parameters in older persons aged 80 years and older.Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study.In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1 High Density Lipoprotein and it's Dysfunction Gene Therapy Targeting LDL Cholesterol but not HDL Cholesterol Induces Regression of Advanced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study.Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI Roles of High-Density Lipoprotein Cholesterol in Patients With Acute Myocardial Infarction.Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides.Excess coronary artery disease risk in South Asian immigrants: can dysfunctional high-density lipoprotein explain increased risk?Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis

P2860

Q24647387-E0AEACA2-40BE-4E57-A14E-D161D7C15D9A Q26852155-9676B107-5625-4096-997A-EEC4D1637B48 Q28304559-64D8408C-C041-4D18-8B6D-FEDE6B8394E0 Q28395898-E7CA8147-FD73-430F-8163-8A3DDE105FC2 Q28479210-25679688-C2E7-439A-87D2-B037BD442194 Q28544713-45D1AC81-9FB8-4B9E-9251-9DFCF2B520EA Q33544033-08D0F659-E4B8-437E-9DD6-A19FC7D9C8D6 Q33556997-79954617-E371-46C6-A5F5-F891FE4C6393 Q33566579-E9037319-BE56-4671-ADA4-F1EAF6422B7B Q33687843-63CDA604-B9B5-447F-AD0E-08E53D736A48 Q33736211-CB1843BE-4C96-4854-BFBA-AC134718BB2D Q33903196-3BF0786E-3266-4DDB-BB5F-BA053D19FED7 Q33993060-E91D7307-32AF-476E-98A6-5316A36A19BF Q34022219-BE3422AA-7570-4092-884F-EF58F765AB7C Q34104339-AA23DE00-4A6C-489E-865E-A79899A44568 Q34128231-0DEC70BB-3203-4BCD-9FC6-D6E0410383D0 Q34156600-90AC3B2B-D420-4E69-A696-825629E51A40 Q34203358-0B6054CE-8A05-4053-AF37-96E25DE36479 Q34334697-20CB9D78-17D7-44FC-9F6B-857055CC5FA9 Q34466725-CB10CBA4-7510-4BDB-9FE5-1E7BB0573DF5 Q34504092-56E9B798-91F3-4C45-B591-7559AB6DDA3A Q35068678-BC5D8363-A116-403F-B356-169B4119EB85 Q35149530-C40E7D23-130D-47EE-B536-CFFEAA90ECD6 Q35282669-BE07EC8A-13D7-43ED-A817-DE066633131A Q35600786-972B0230-E617-48C4-AFB6-317961FF382A Q35760064-0DA35AC6-10F5-4632-BBC0-6F3BACA1166D Q35886290-AB0918C0-B398-4C1E-B24A-92556CA6BE5F Q36002630-A713F7CE-8082-4877-8CD1-928F1DEB1B00 Q36150462-86A92757-DB4B-4A0B-96B1-2C6D17C93743 Q36344509-523BE182-DC39-4D72-A77B-868382730BA4 Q36404574-57CB3466-BE0F-4A4D-A6D9-AA6DA7B5204B Q36441429-6D95863F-6FE2-408A-8D68-E6FC539FD772 Q36445823-0047FBCE-C55D-4CBA-AF73-1039ADC18F11 Q36891753-946F3D7F-259A-47D3-93BB-E24EFEF856D3 Q36944127-86243100-C795-41D1-B756-466FC55BE4DD Q36955395-94240FF8-E7C8-454F-A022-1DEAFB160582 Q36973725-FCE1102B-F636-4CF1-ADCC-24C69912558D Q37019901-C0C4F277-FABB-4E35-867E-1DC0AAA7B6C7 Q37033119-55C6F9F7-5451-40E7-B822-9A62CFC30807 Q37104740-3D674F36-1009-423C-83CA-0B1FDBAFBDC0

P2860

Mechanisms of disease: proatherogenic HDL--an evolving field.

http://www.wikidata.org/entity/Q36587579

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Mechanisms of disease: proatherogenic HDL--an evolving field.

@ast

Mechanisms of disease: proatherogenic HDL--an evolving field.

@en

type

label

Mechanisms of disease: proatherogenic HDL--an evolving field.

@ast

Mechanisms of disease: proatherogenic HDL--an evolving field.

@en

prefLabel

Mechanisms of disease: proatherogenic HDL--an evolving field.

@ast

Mechanisms of disease: proatherogenic HDL--an evolving field.

@en

P1433

Q36587579-CE0E6DA5-21BD-4995-B889-741759D820D5

P1476

Q36587579-176F3DD7-3160-4B45-893D-83B360DAD655

P2093

Q36587579-357A22B4-DDFF-498C-91C2-18FB29247151

Q36587579-461FF0C9-5F5B-441B-9F8D-28F59CB752B5

Q36587579-9C463EDC-A713-4B16-8F7D-716794D7F5AE

Q36587579-9D1D0AE9-4DF9-49CE-B440-675CB0CF1B37

Q36587579-DE97992A-2F56-478F-8292-D50307ECD9C6

Q36587579-FC7A9564-71C7-48CE-ACD5-4F61DB8E6741

P2860

Q36587579-146C5CB4-04DD-4C0C-B249-FBE6EABB33C5

Q36587579-397B9278-3AEC-4B8A-A893-904CD334C1D5

Q36587579-62EE9FB9-8020-43A7-AB22-14B6A10EBD59

Q36587579-BB45285D-33FB-49FD-9872-D557448C21FF

Q36587579-DE106716-5875-4CB7-A14D-D666ABD24B67

P304

Q36587579-D1D3EE2C-ECFA-462C-ACB7-E84E5B8EAEA7

P31

Q36587579-E3FAF400-CFFA-4C78-B2C5-384125CFB9C2

P356

Q36587579-C2D3CE0D-5135-4DC6-81FF-AE8828AC0756

P433

Q36587579-F9D399BC-63D5-4289-9AF6-760B16152436

P478

Q36587579-14E49EDA-2912-404D-AB38-A69E6564F676

P577

Q36587579-B770E2AA-EEF0-42A0-AAC1-00129FAD6A71

P698

Q36587579-B448A82A-A054-44A1-9A41-B0F7F63A6CCB

P356

P1433

Nature Clinical Practice Endocrinology and Metabolism

P1476

Mechanisms of disease: proatherogenic HDL--an evolving field.

@en

P2093

Alan M Fogelman

http://www.w3.org/2001/XMLSchema#string

Benjamin J Ansell

http://www.w3.org/2001/XMLSchema#string

Brian J Van Lenten

http://www.w3.org/2001/XMLSchema#string

Gattadahalli M Anantharamaiah

http://www.w3.org/2001/XMLSchema#string

Mohamad Navab

http://www.w3.org/2001/XMLSchema#string

Srinivasa T Reddy

http://www.w3.org/2001/XMLSchema#string

P2860

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.

Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles.

Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.

P304

504-511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPENDMET0245

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16957764

http://www.w3.org/2001/XMLSchema#string